Tarsus Pharmaceuticals, Inc. (TARS)

CIK 1819790 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tarsus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G0000315066-26-002878
Nov 3, 20268-K0001819790-26-000074
Nov 3, 202610-Q0001819790-26-000076
Oct 13, 20268-K/A0001819790-26-000069
Oct 13, 2026S-3ASR0001193125-26-420618
Oct 13, 2026S-3ASR0001193125-26-420490
Sep 17, 202640001051578-26-000010
Sep 17, 202640001228684-26-000010
Sep 17, 202640001181186-26-000008
Sep 15, 20261440001628280-26-062078
Sep 10, 20268-K0001819790-26-000066
Sep 9, 202640001842190-26-000011
Sep 9, 202640001827672-26-000013
Sep 9, 202640001827584-26-000013
Sep 4, 20261440001959173-26-006760
Sep 4, 20261440001959173-26-006758
Sep 4, 20261440001959173-26-006753
Sep 4, 20261440001628280-26-060766
Sep 3, 202640001827672-26-000011
Sep 3, 202640001842190-26-000009
Sep 2, 20261440001959173-26-006652
Sep 2, 20261440001628280-26-060042
Sep 2, 20261440001959173-26-006670
Sep 2, 20261440001959173-26-006653
Sep 1, 20261440001959173-26-006607